CAS： 101831-37-2
MF： C17H9Cl3N4O2
Appearance： Yellowish or white powder
Diclazuril is a triazinone antiprotozoal that is effective for treating infections caused by Isospora spp., Toxoplasma gondii, and Eimeria spp. and has been used for treating coccidiosis. It also has been used in horses to treat equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. Ionophores, such as monensin, narasin and lasalocid, are defined as antibiotics by the USDA, while chemical anticoccidials, such as nicarbazin, robenidine, clopidol and diclazuril are not antibiotics and may be used in no antibiotics ever (NAE) labelled poultry. Diclazuril is a safe compound with no known side effects at therapeutic dose levels. However, diclazuril has not been tested or used in pregnancy.
Hebei KuiSheng Trading Co., LTD ，a company specializing in the production and supply of chemicals for various industries. we take pride in our ability to carefully formulate chemicals that meet the highest standards of quality, efficiency, and safety. Through advanced technology and strict quality control measures, we ensure that our products consistently deliver exceptional performance and reliability. Whether you are in need of chemicals for pharmaceutical, agricultural, or industrial applications, we offer a wide range of solutions to meet your specific requirements. Our team is dedicated to providing excellent customer service and we strongly believe in establishing long-lasting business relationships built on trust and mutual success. Allow me to outline some of our key advantages: 1. High quality with competitive prices: We strive to offer chemicals of the highest quality while remaining competitive in the market. 2. All purity >99%: Our products undergo rigorous purification processes to guarantee high purity levels. 3. Manufacturer with factory prices: As a manufacturer, we have the ability to offer high-quality products at competitive factory prices. 4. Fast and safe delivery: We understand the importance of timely and secure deliveries.
